Technical retreat for leaders preparing sterile injectable programs for Phase III and commercial launch.
In partnership with
Event Overview
Advancing from Phase III to Market: Navigating Modality Complexity, Capacity Security, and Geopolitical Risk
Event Details
Date
September 2, 2026
Venue
Curia Albuquerque Facility
Albuquerque, NM,
USA
Format
Executive Summit
Biotech Targeting provides optional logistical support for confirmed delegates, including the coordination of travel and accommodations, to facilitate seamless attendance
To ensure a high-level technical dialogue, attendance at this summit is strictly limited to 15–20 senior industry leaders.
Event Overview
Advancing from Phase III to Market: Navigating Modality Complexity, Capacity Security, and Geopolitical Risk
Securing Sterile Injectable Supply: An Executive Summit is a retreat designed for leaders preparing therapies for Phase III and commercial launch. We're bringing together a small group of peers for a unique experience in a unique setting. Join us for focused discussion, candid networking, and a practical deep dive into the market drivers reshaping sterile injectable supply today.
Step away from the noise of the traditional trade show conference floor and into a setting built for clearer thinking, with space to relax, reset, and take in the breathtaking Sandia Mountain views. You'll enjoy a day-long working conversation about capacity, complexity, quality expectations, and supply chain risk.
Attendees will have ample time to network with their peers, and will have the opportunity to tour Curia's two newest sterile drug product lines. This focused, one-day summit combines expert panels, facility tours, lightning sessions, and peer roundtables. To ensure a seamless experience for our selected executive cohort, this summit is entirely complimentary, with all flights, local accommodations, and private dining fully hosted by Biotech Targeting and Curia.
What's Included
This summit is strictly limited to an intimate cohort of 15–20 senior industry leaders. To ensure a seamless journey to Albuquerque, Biotech Targeting provides optional logistical coordination for all event attendees:
Optional round-trip flight coordination from any major US hub to Albuquerque is available via Biotech Targeting.
Biotech Targeting offers optional assistance in securing preferred local hotel accommodations for the duration of the event.
Access to all private networking lunches, the closing reception, and optional strategy dinners.
All interactive roundtables, specialized technical presentations, and advanced aseptic facility tours.
Key Benefits of Attending
Designed specifically for senior decision-makers transitioning from clinical supply to commercial manufacturing.
Gain actionable, real-world strategies to compress the timeline from late-stage clinical trials to market entry, including a deep dive into an 18-month shortcut to safely transition from Phase II to commercial supply.
Learn how to proactively adapt your Chemistry, Manufacturing, and Controls (CMC) strategy to navigate major industry disruptions, including the Biosecure Act, shifting global dynamics, and the need for a resilient, US-based manufacturing footprint.
Get a firsthand look at cutting-edge fill-finish capabilities, including a live demonstration of the "Zero-Loss" VarioSys system, and discover how to align your processes with stringent regulatory standards like EU GMP Annex 1.
Explore technical insights on managing complex commercial modalities, including LNPs, proteins, peptides, and mAbs, and master the operational pivot from vials to high-demand pre-filled syringes.
Tour Curia's state-of-the-art Albuquerque facility and engage in an open, rapid-fire Q&A forum directly with site leadership to solve your complex tech transfer, scale-up, and process validation bottlenecks.
Connect and collaborate during peer-to-peer interactive roundtables and dedicated networking sessions with exclusive, senior-level decision-makers across CMC, Tech Ops, Quality, and Global Supply Chain Management.
Who Should Attend
Specifically designed for senior leaders navigating the transition from clinical supply to commercial manufacturing.
Including titles such as:
Chief Technical Officer (CTO) / Chief Operating Officer (COO)
VP / SVP of Tech Ops, CMC, or Quality Operations
Head of Commercial Manufacturing or Sterile Operations
Director of Process Validation, Engineering, or Global Supply Chain
Senior Director of Quality Assurance, Compliance, and Regulatory Affairs
Agenda
A focused, one-day summit combining expert panels, facility tours, lightning sessions, and peer roundtables. Registration includes optional, complimentary access to private strategy dinners hosted the evening before and the night of the event.
Built for the sterile injectables community, by the leaders shaping it. Gain actionable strategies from the executives successfully scaling therapies from Phase III to commercial launch.
Curia supports programs from early-stage development through commercial manufacturing, with services across drug product development, clinical manufacturing, and commercial manufacturing. Its network provides sterile fill-finish capabilities, formulation and process development support, lyophilization expertise, and capacity in vials, pre-filled syringes, and cartridges. Curia works with complex APIs and sterile injectable formats, including solutions, suspensions, emulsions, lipid nanoparticles, and lyophilized dosage forms. Its sterile drug product sites include clinical development and manufacturing locations in Camarillo, California, and Glasgow, UK, as well as a commercial sterile drug product location in Albuquerque, New Mexico, supporting late-phase clinical and commercial work.
West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients.
Gerresheimer AG is a leading global partner to the pharma and biotech industries, providing innovative, high-quality specialized glass and plastic containment solutions and drug delivery systems. As a trusted partner from development to commercial scale, Gerresheimer helps ensure the safe, reliable storage and precise administration of critical medicines for patients worldwide.
An Exclusive, Executive-Level Gathering
To deliver a high-impact, actionable deep-dive into sterile supply chain security, attendance is strictly limited to 15–20 CMC, Supply Chain and Technical Operations executives. This invitation-only summit is designed to provide rare, behind-the-scenes access to Curia's newest sterile drug product lines and facilitate high-level strategy sessions with your industry peers.
Registration is entirely complimentary and includes all round-trip flights, premium accommodations, and private dining access. Due to strict capacity constraints at the facility and our private evening venues, seats will be allocated on a first-come, first-served basis to qualified leaders.
Secure your place today to join your peers and de-risk your Phase II to commercial pipeline.
Register Now
Attendance is limited to 15-20 senior leaders.
Registration is fully complimentary, including all travel, premium accommodations, and private dining.
Discuss your objectives with our senior consultants or get the prospectus for our next invitation-only meetings.
Connecting innovators in pharma and biotech through bespoke B2B engagement formats.
Address:
Bmlg.02 10 Barley Mow Passage,
London, United Kingdom, W4 WPH